Research in cancer cells revealed a positive association between CD36 and AKT [101], suggesting that CAVPENET inhibition of AKT might be responsible for reducing the availability of fatty acids in PCa cells, via distinct mechanisms. This evidence concerns the gene AKT1 and cancer.